Drug
Topical therapy
Topical therapy is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Phase Distribution
Ph phase_3
1
33%
Ph not_applicable
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution2 total trials
Phase 3Large-scale testing
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(1)
Other(1)
Detailed Status
Withdrawn1
Completed1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 31 (50.0%)
N/A1 (50.0%)
Trials by Status
withdrawn133%
completed133%
unknown133%
Recent Activity
0 active trials
Showing 3 of 3
withdrawn
Evaluation of Vitamin D Levels in Psoriasis Patients
NCT01903317
completedphase_3
A Phase 3B, Open-label, Single-arm Study of the Efficacy and Safety of Apremilast, in Subjects With Plaque Psoriasis That is Not Adequately Controlled by Topical Therapy
NCT03930186
unknownnot_applicable
Safety and Efficacy of a Novel Topical Therapy for Tinea Pedis (Athlete's Foot)
NCT00848666
Clinical Trials (3)
Showing 3 of 3 trials
NCT01903317
Evaluation of Vitamin D Levels in Psoriasis Patients
NCT03930186Phase 3
A Phase 3B, Open-label, Single-arm Study of the Efficacy and Safety of Apremilast, in Subjects With Plaque Psoriasis That is Not Adequately Controlled by Topical Therapy
NCT00848666Not Applicable
Safety and Efficacy of a Novel Topical Therapy for Tinea Pedis (Athlete's Foot)
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3